Thromb Haemost 1995; 74(01): 464-472
DOI: 10.1055/s-0038-1642723
Symposium
New Antithrombins
Schattauer GmbH Stuttgart

Antithrombotic Benefits and Hemorrhagic Risks of Direct Thrombin Antagonists

Laurence A Harker
Division of Hematology and Oncology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
,
Stephen R Hanson
Division of Hematology and Oncology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
,
Andrew B Kelly
Division of Hematology and Oncology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
09. Juli 2018 (online)